ImmunoCAP® Molecular Allergology pinpoints disease-causing
allergens, for unparalleled insight into allergy
Now you can take allergy diagnosis to a whole new level. Because Phadia, pioneers in allergy testing with
nearly 40 years of expertise, are pleased to bring you
ImmunoCAP Molecular Allergology
.
It’s the most
precise, comprehensive and advanced diagnostic technology available today.
Unlike traditional allergy testing,
ImmunoCAP Molecular Allergology
uses single allergen components
to quantitatively detect IgE antibodies. It’s a level of insight previously unimaginable – one that gives you
the ability to accurately assess the risk of allergic reaction, identify cross-reactivity patterns, and determine
a patient’s suitability for specific immunotherapy. All of which means that you can help your patients put their
allergy in perspective, and get back to enjoying life.
To learn more about the advancements we’re making in allergy testing, contact your local Phadia
representative or visit
.
ALLERGY
AS YOU’VE
NEVER SEEN IT
ImmunoCAP is a registered trademark of Phadia AB.
ll r
,
f r
r ll l i i
i
ll r
Now you can take allergy diagnosis to a whole new level. Because Phadia, pioneers in allergy testing with
nearly 40 years of expertise, are pleased to bring you
ImmunoCAP Molecular Allergology
.
It’s the most
precise, comprehensive and advanced diagnostic technology available today.
Unlike traditional allergy testing,
ImmunoCAP Molecular Allergology
uses single allergen components
to quantitatively detect IgE antibodies. It’s a level of insight previously unimaginable – one that gives you
the ability to accurately assess the risk of allergic reaction, identify cross-reactivity patterns, and determine
a patient’s suitability for specific immunotherapy. All of which means that you can help your patients put their
allergy in perspective, and get back to enjoying life.
To learn more about t
’re making in allergy testing, contact your local Phadia
representative or visit
.
ImmunoCAP is a registered trademark of Phadia AB.
